Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeueHealth, Inc. Common Stock (NY: NEUE )

6.760 +0.040 (+0.60%)
Streaming Delayed Price Updated: 12:09 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,118
Open 6.900
Bid (Size) 6.660 (4)
Ask (Size) 6.770 (2)
Prev. Close 6.720
Today's Range 6.524 - 6.900
52wk Range 3.790 - 7.660
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
From NeueHealth
Via Business Wire
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-7.78%
-7.78%
1 Month
+8.16%
+8.16%
3 Month
-8.03%
-8.03%
6 Month
+22.91%
+22.91%
1 Year
+9.92%
+9.92%

More News

Read More
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
From NeueHealth
Via Business Wire
Earnings Scheduled For March 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
From NeueHealth
Via Business Wire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NEUE, VCSA, SSTK, NARI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MoneyLion Inc. (NYSE - ML), Marinus Pharmaceuticals, Inc. (Nasdaq - MRNS), Better Choice Inc. (NYSE American - BTTR), NeueHealth, Inc. (NYSE - NEUE)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, NEUE, VINC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PWOD, VOXX, NEUE on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst
Via Benzinga
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NeueHealth, Limoneira And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
NEUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeueHealth, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
NeueHealth to Be Taken Private by NEA and Consortium of Investors
From NeueHealth
Via Business Wire
Neuehealth Reports Third Quarter 2024 Results
From NeueHealth
Via Business Wire
NeueHealth Acquires Full Ownership of Centrum Health
From NeueHealth
Via Business Wire
NeueHealth to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024
From NeueHealth
Via Business Wire
NeueHealth Reports Second Quarter 2024 Results
From NeueHealth
Via Business Wire
NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024
From NeueHealth
Via Business Wire
NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital
From NeueHealth
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.